Safety and efficacy of same-day discharge for premature ventricular complex ablations
Europace · 2024
DOI: 10.1093/europace/euae205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Mathew S Padanilam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Chicago, 5841 South Maryland Avenue, MC 7082, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Ventricular Premature Complexes, Catheter Ablation, Patient Discharge. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: St Vincent Cardiovascular Research Institute.
Abstract (Originalsprache)
Aims
Patients undergoing catheter ablation (CA) of ventricular arrhythmias (VAs) are generally observed overnight in the hospital given the concern for complications. To evaluate the efficacy and safety of same-day discharge (SDD) of patients undergoing elective CA of premature ventricular complexes (PVCs). Methods and results A retrospective evaluation of all patients undergoing elective VA ablation at Ascension St Vincent Hospital from 1 January 2018 to 31 December 2019 was undertaken. Of those, the patients undergoing PVC ablation were divided into SDD and non-SDD. Patients underwent SDD at the discretion of the operator. The primary safety outcome was the 30-day incidence of complications and death. The primary efficacy outcome was procedural success. Among 188 patients who underwent VA ablation, 98 (52.1%) were PVC ablations, and of those, 55 (56.1%) were SDD. There was no difference in age, gender, comorbidities, or ejection fraction between the two groups. Patients that were non-SDD were more likely to be on chronic anticoagulation (P = 0.03), have ablation in the LV (P = 0.04), have retrograde access (P = 0.03), and receive heparin during the procedure (P = 0.01). There were no complications in the SDD group compared with one (2.3%) in the non-SDD group. There was no difference in primary efficacy between the two groups with a 90.9% acute success in the SDD and 88.4% in the non-SDD (P = 0.68).
Conclusion
Same-day discharge for CA of PVCs is feasible and could lower healthcare resource utilization without compromising outcomes in this unique population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Chicago, 5841 South Maryland Avenue, MC 7082, Chicago, IL 60637, USA.
- Department of Internal Medicine, Division of Cardiology, Ascension St Vincent, 8333 Naab Road, #400, Indianapolis, IN 46260, USA.
ORCID-Profile: Mathew S Padanilam, Parin J Patel, Sandeep A Joshi, Girish V Nair, Bradley A Clark, Ankur Shah, Jasen L Gilge
Förderung
- St Vincent Cardiovascular Research Institute
Zitieren
APA
Padanilam, M. S., Patel, P. J., Joshi, S. A., Nair, G. V., Clark, B. A., Shah, A., Field, J., Prystowsky, E. N., & Gilge, J. L. (2024). Safety and efficacy of same-day discharge for premature ventricular complex ablations. Europace. https://doi.org/10.1093/europace/euae205
Vancouver
Padanilam MS, Patel PJ, Joshi SA, Nair GV, Clark BA, Shah A, et al. Safety and efficacy of same-day discharge for premature ventricular complex ablations. Europace. 2024. doi:10.1093/europace/euae205
BibTeX
@article{Padanilam2024,
author = {Padanilam, Mathew S and Patel, Parin J and Joshi, Sandeep A and Nair, Girish V and Clark, Bradley A and Shah, Ankur and Field, Justin and Prystowsky, Eric N and Gilge, Jasen L},
title = {Safety and efficacy of same-day discharge for premature ventricular complex ablations},
journal = {Europace},
year = {2024},
doi = {10.1093/europace/euae205}
}
EUVIMED